Sargramostim

In the US, Sargramostim (sargramostim systemic) is a member of the drug class colony stimulating factors and is used to treat Aplastic Anemia, Bone Marrow Transplantation, Bone Marrow Transplantation - Failure or Engraftment Delay, Bone Marrow Transplantation - Myeloid Reconstruction and Neutropenia Associated with Chemotherapy.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AA09

CAS registry number (Chemical Abstracts Service)

0123774-72-1

Chemical Formula

C639-H1002-N168-O196-S8

Molecular Weight

14431

Therapeutic Categories

Immunomodulator

Colony stimulating factor, granulocyte-macrophage, GM-CSF

Chemical Name

23-L-Leucinecolony-stimulating factor 2 (human clone pHG25 protein moiety)

Foreign Names

  • Sargramostimum (Latin)
  • Sargramostim (German)
  • Sargramostim (French)
  • Sargramostim (Spanish)

Generic Names

  • Sargramostim (OS: BAN, USAN, DCF)
  • BI 61012 (IS)
  • BL 400 (IS)
  • rGM-CSF (IS)
  • rHu GM-CSF (IS)
  • Sargramostim (PH: USP 34)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)